The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Asialoglycoprotein Receptor Deficiency in Mice Lacking the Major Receptor Subunit
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previously established Asgr1-knockout mice by replacing exons 2-3 were unable to clear asialofetuin and asialo-orosomucoid.
“Previously, Asgr1-knockout mice were established by replacing exons 2–3, which contain the ATG translational initiation codon and transmembrane domain (27). These ASGR1-knockout mice were unable to clear asialofetuin and asialo-orosomucoid.”
From Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression (2021) · cites this paper as [27]
The Experimental Procedures describe replacing the fragment containing exons 2–3 to generate MHL-1 knockout mice. The Results report severely impaired clearance of both asialofetuin and asialo-orosomucoid, but not an inability to clear them: at 30 minutes, 40% and 65% of the respective doses remained in knockout mice. (LLM, conf=0.91)
Experimental — accuracy not yet measuredIn previously established Asgr1-knockout mice, measurements of LDL and VLDL revealed a decreased trend with large standard deviations without a statistical difference, and serum TC and TG contents had no significant difference.
“However, the measurements of LDL and VLDL revealed a decreased trend with large standard deviations without a statistical difference, and the serum TC and TG contents also had no significant difference.”
From Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression (2021) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455
Flagged first, then by citations
Research works printed but not linked: 33
- Ashwell, 1974, Adv. Enzymol. Relat. Areas Mol. Biol., 41, 99, 10.1002/9780470122860.ch3 · DOI
- Spiess, 1990, Biochemistry, 29, 10009, 10.1021/bi00495a001 · DOI
- Stockert, 1995, Physiol. Rev., 75, 591, 10.1152/physrev.1995.75.3.591 · DOI
- Lodish, 1991, Trends Biochem. Sci., 16, 374, 10.1016/0968-0004(91)90154-N · DOI
- Halberg, 1987, J. Biol. Chem., 262, 9828, 10.1016/S0021-9258(18)48008-8 · DOI
- Drickamer, 1988, J. Biol. Chem., 263, 9557, 10.1016/S0021-9258(19)81549-1 · DOI
- Windler, 1991, Biochem. J., 276, 79, 10.1042/bj2760079 · DOI
- Ishibashi, 1996, J. Biol. Chem., 271, 22422, 10.1074/jbc.271.37.22422 · DOI · Paper page
- Rifai, 2000, J. Exp. Med., 191, 1171, 10.1084/jem.191.12.2171 · DOI
- Rotundo, 1998, Hepatology, 28, 475, 10.1002/hep.510280227 · DOI
- Treichel, 1994, J. Gen. Virol., 75, 3021, 10.1099/0022-1317-75-11-3021 · DOI
- Becker, 1995, J. Gen. Virol., 76, 393, 10.1099/0022-1317-76-2-393 · DOI
- Dotzauer, 2000, J. Virol., 74, 10950, 10.1128/JVI.74.23.10950-10957.2000 · DOI
- Ishibashi, 1994, J. Biol. Chem., 269, 27803, 10.1016/S0021-9258(18)46855-X · DOI
- Broun, 1996, J. Biol. Chem., 271, 21160, 10.1074/jbc.271.35.21160 · DOI
- Braiterman, 1989, J. Biol. Chem., 264, 1682, 10.1016/S0021-9258(18)94240-7 · DOI
- Geffen, 1989, EMBO J., 8, 2855, 10.1002/j.1460-2075.1989.tb08433.x · DOI
- Soukharev, 2000, Gene, 241, 233, 10.1016/S0378-1119(99)00493-X · DOI
- Soriano, 1991, Cell, 64, 693, 10.1016/0092-8674(91)90499-O · DOI
- Tozawa, 1999, J. Biol. Chem., 274, 30843, 10.1074/jbc.274.43.30843 · DOI
- Yagyu, 1999, J. Lipid Res., 40, 1677, 10.1016/S0022-2275(20)33414-3 · DOI
- Shia, 1989, Proc. Natl. Acad. Sci. U. S. A., 86, 1158, 10.1073/pnas.86.4.1158 · DOI
- Wikstrom, 1992, J. Biol. Chem., 267, 5, 10.1016/S0021-9258(18)48445-1 · DOI
- Wikstrom, 1993, J. Biol. Chem., 168, 14412, 10.1016/S0021-9258(19)85255-9 · DOI
- Oda, 1988, J. Biochem., 104, 600, 10.1093/oxfordjournals.jbchem.a122518 · DOI
- Ii, 1990, J. Biol. Chem., 265, 11295, 10.1016/S0021-9258(19)38590-4 · DOI
- Kido, 1999, FEBS Lett., 464, 75, 10.1016/S0014-5793(99)01681-6 · DOI
- Drickamer, 1991, Cell, 67, 1029, 10.1016/0092-8674(91)90278-7 · DOI
- Rutondo, 1999, Am. J. Physiol., 277, G1189
- Schauer, 1985, Clin. Chim. Acta, 146, 119, 10.1016/0009-8981(85)90050-6 · DOI
- Weigel, 1994, Bioessays, 16, 519, 10.1002/bies.950160713 · DOI
- Marshall, 1974, J. Clin. Invest., 54, 555, 10.1172/JCI107792 · DOI
- Sawamura, 1981, Gastroenterology, 81, 527, 10.1016/0016-5085(81)90605-3 · DOI
Cited by
Sorted by citations
The Ashwell receptor mitigates the lethal coagulopathy of sepsis
Grewal, P. K., Uchiyama, S., Ditto, D., Varki, N., Le, D. T., Nizet, V., & Marth, J. D. (2008) · Nature Medicine · doi:10.1038/nm1760 · Cited by 374
Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion
Wang, J.-Q., Li, L.-L., Hu, A., Deng, G., Wei, J., Li, Y.-F., Liu, Y.-B., Lu, X.-Y., Qiu, Z.-P., Shi, X.-J., et al. (2022) · Nature · doi:10.1038/s41586-022-05006-3 · Cited by 188
An intrinsic mechanism of secreted protein aging and turnover
Yang, W. H., Aziz, P. V., Heithoff, D. M., Mahan, M. J., Smith, J. W., & Marth, J. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515464112 · Cited by 110
Wahrenbrock, M. G., & Varki, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3851 · Cited by 58
Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression
Xu, Y., Tao, J., Yu, X., Wu, Y., Chen, Y., You, K., Zhang, J., Getachew, A., Pan, T., Zhuang, Y., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147038 · Cited by 45
Improving sialylation of recombinant biologics for enhanced therapeutic efficacy
Chan, K. F., Goh, J. S., & Song, Z. (2014) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.44 · Cited by 4
Metadata
- Authors
- Tozawa, R.-I., Ishibashi, S., Osuga, J.-I., Yamamoto, K., Yagyu, H., Ohashi, K., Tamura, Y., Yahagi, N., Iizuka, Y., Okazaki, H., Harada, K., Gotoda, T., Shimano, H., Kimura, S., Nagai, R., & Yamada, N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 276
- Issue
- 16
- Pages
- 12624-12628
- ISSN
- 0021-9258
- Cited by
- 78
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review